TCGX Acquisition (TCGX)
TCGX Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combin...
- Open
- 14.000
- High
- 14.110
- Low
- 14.000
- Prev. Close
- 14.020
- Volume
- 1.46K
- Turnover
- 20.38K
- Avg Price
- 13.979
- Bid/Ask Ratio
- 33.33%
- Amplitude
- 0.78%
- 52wk High
- 18.910
- Volume Ratio
- 0.00
- Turnover Ratio
- 0.02%
News
- PUBT · Aug 12 at 07:44 AM
Vaderis Therapeutics raises $152 million in Series B financing
- PR Newswire · Aug 11 at 06:54 AM
EQT Life Sciences participates in Vaderis Therapeutics' USD 152 million Series B financing
- Unusual Whales · Aug 11 at 06:13 AM
Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia
